Diagnosis and Treatment of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Diseases due to Initiation of Anti-Tumor Necrosis Factor Therapy

Patients with intractable inflammatory bowel diseases (IBD) are increasingly being treated with anti-tumor necrosis factor (TNF) agents and are at increased risk of developing tuberculosis (TB). Therefore, diagnosis and treatment of latent TB infection (LTBI) is recommended in patients due to the in...

Descripción completa

Detalles Bibliográficos
Autor principal: Shim, Tae Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204689/
https://www.ncbi.nlm.nih.gov/pubmed/25349559
http://dx.doi.org/10.5217/ir.2014.12.1.12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204689/
https://www.ncbi.nlm.nih.gov/pubmed/25349559
http://dx.doi.org/10.5217/ir.2014.12.1.12

Ejemplares similares